ASIAMEDIC LIMITED — AGM Information 2026

May 28, 2026

ASIAMEDIC LIMITED

(Incorporated in the Republic of Singapore)

Registration No.:197401556E

(the "Company")

Minutes of the Annual General Meeting of the Company held at Seminar Room 1 & 4, Singapore Business Federation, 160 Robinson Road #06-01, SBF Center, Singapore 068914 on Wednesday, 29 April 2026 at 3:00 p.m.

Present:

Board of Directors

Mr Charles Wang Chong Guang – Non-Executive Chairman
Ms Alice Ng Bee Yee – Independent Director
Mr Chua Keng Woon – Independent Director

In attendance

Ms Foo Soon Soo – Company Secretary
Mr Arifin Kwek – Chief Executive Officer
Ms Syenny Yu – Chief Financial Officer
Mr Gilbert Lee – Partner, Baker Tilly TFW LLP

Other attendees

Continuing Sponsor, polling agent, scrutineer, other professionals, and shareholders as set out in the attendance records maintained by the Company.

1.	WELCOME NOTE AND QUORUM
	The Chairman of the Board of Directors, Mr Charles Wang, chaired the Annual General Meeting (“AGM”). Having noted that a quorum was present, he called the meeting to order. The Chairman thanked shareholders and all those present for their attendance. The Chairman introduced the Directors at the meeting, and informed shareholders that Ms Aona Liu, Director of the Company, was called away on an urgent business commitment and conveyed her apologies to the shareholders. He further informed the meeting that another Director, Mr Leong Yew Meng, was unwell and could not attend the meeting.
2.	VOTING
	The Chairman informed the meeting that all the resolutions as set out in the Notice of the AGM dated 13 April 2026 would be put to vote by way of electronic poll.
The Chairman also informed the meeting that the Company had appointed Complete Corporate Services Pte Ltd as the polling agent and Moore Stephens LLP as the scrutineer.
The polling agent, Complete Corporate Services Pte Ltd, then explained the polling procedures.
3.	NOTICE OF MEETING
	As the Notice of the AGM dated 13 April 2026 convening the AGM had been issued and published on SGXNet and the Company’s website, it was taken as read.

---

ASIAMEDIC LIMITED
Minutes of the AGM held on 29 April 2026
Page 2 of 5

4.	AUDITED FINANCIAL STATEMENTS, DIRECTORS’ STATEMENT AND AUDITORS’ REPORT FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025 (ORDINARY RESOLUTION 1)
	The Chairman addressed the first item on the agenda which was to approve the audited financial statements for the financial year ended 31 December 2025 together with the Directors’ Statement and Auditors’ Report.

The Chairman invited questions from shareholders and no questions were raised.

The following resolution was proposed by a shareholder:
“That the Audited Financial Statements for the financial year ended 31 December 2025 together with the Directors’ Statement and Auditors’ Report thereon be and is hereby received and adopted.”

The resolution was put to vote by poll. The result was as follows: | | | |
| | For | % of total votes | Against | % of total votes |
| | 476,002,546 | 100.00 | 0 | 0.00 |
| | The Chairman declared the resolution carried. | | | |
| 5. | RE-ELECTION OF DIRECTOR – MR CHARLES WANG CHONG GUANG (ORDINARY RESOLUTION 2) | | | |
| | Resolution 2 dealt with the re-election of Mr Charles Wang Chong Guang, a Director retiring under Regulation 89 of the Company’s Constitution. Mr Charles Wang would, upon being re-elected as a Director, remain as the Chairman of the Board, and a member of the Audit and Risk Management Committee and the Remuneration Committee. He would continue to be considered non-independent for the purpose of Rule 704(7) of the Catalist Rules of the Singapore Exchange Securities Trading Limited.

The Chairman requested Mr Chua Keng Woon to preside over the meeting.

The following resolution was proposed by a shareholder:
“That Mr Charles Wang Chong Guang be and is hereby re-elected as a Director of the Company.”

The resolution was put to vote by poll. The result was as follows: | | | |
| | For | % of total votes | Against | % of total votes |
| | 475,185,546 | 99.83 | 817,000 | 0.17 |
| | Mr Chua declared the resolution carried and handed the chair back to the Chairman. | | | |

---

ASIAMEDIC LIMITED
Minutes of the AGM held on 29 April 2026
Page 3 of 5

6.	RETIREMENT OF MR LEONG YEW MENG
	The Chairman informed the meeting that Mr Leong Yew Meng would retire as Independent Director at the conclusion of the AGM. The Board thanked Mr Leong for his invaluable contribution during his tenure.
7.	DIRECTORS' FEE (ORDINARY RESOLUTION 3)
	The following resolution was proposed by a shareholder: "That Directors' fee of S$173,000 for the financial year ended 31 December 2025 be and is hereby approved." The resolution was put to vote by poll. The result was as follows:
	For	% of total votes	Against	% of total votes
	475,185,546	100.00	0	0.00
	The Chairman declared the resolution carried.
8.	RE-APPOINTMENT OF AUDITORS (ORDINARY RESOLUTION 4)
	The Chairman informed the meeting that the Audit and Risk Management Committee had recommended the re-appointment of Baker Tilly TFW LLP as Auditors of the Company. Baker Tilly TFW LLP had expressed its willingness to accept re-appointment as Auditors. The following resolution was proposed by a shareholder: "That Baker Tilly TFW LLP, Certified Public Accountants, be and are hereby appointed Auditors of the Company until the conclusion of the next annual general meeting at a fee to be agreed between the Directors and the Auditors." The resolution was put to vote by poll. The result was as follows:
	For	% of total votes	Against	% of total votes
	475,785,546	100.00	0	0.00
	The Chairman declared the resolution carried.

---

ASIAMEDIC LIMITED
Minutes of the AGM held on 29 April 2026
Page 4 of 5

9.	AUTHORITY TO ISSUE SHARES AND INSTRUMENTS CONVERTIBLE INTO SHARES (ORDINARY RESOLUTION 5)
	Resolution 5 was to authorise the Directors to allot and issue shares and instruments convertible into shares pursuant to Section 161 of the Companies Act 1967 and Rule 806 of the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited. The text of the resolution was set out in the Notice of the AGM.

The resolution set out under item 6 of the Notice of the AGM was proposed by a shareholder.

The resolution was put to vote by poll. The result was as follows: | | | |
| | For | % of total votes | Against | % of total votes |
| | 475,445,546 | 99.94 | 300,000 | 0.06 |
| | The Chairman declared the resolution carried. | | | |
| 10. | RENEWAL OF THE SHARE PURCHASE MANDATE (ORDINARY RESOLUTION 6) | | | |
| | Resolution 6 was to renew the Share Purchase Mandate. The text of the resolution was set out in the Notice of the AGM. Information relating to the renewal of the Share Purchase Mandate was set out in the Appendix to the Annual Report, which was available on the SGXNet and the Company's website.

Abstention from voting on resolution 6
The Chairman informed the meeting that Integral Lead Limited, Dragon Glorious Limited, Capital Blaze Limited, Ms Aona Liu, himself, and their respective associates were parties presumed to be acting in concert and would abstain from voting on this resolution. He further informed that he would decline proxy appointments without specific instructions as to voting. The Chairman had received proxy appointments, all of which contained specific voting instructions, and he would vote in accordance with those instructions.

The resolution set out under item 7 of the Notice of the AGM was proposed by a shareholder.

The resolution was put to a vote by poll. The result was as follows: | | | |
| | For | % of total votes | Against | % of total votes |
| | 40,461,000 | 100.00 | 0 | 0.00 |
| | The Chairman declared the resolution carried. | | | |
| 11. | AUTHORITY TO ALLOT AND ISSUE SHARES UNDER THE ASIAMEDIC EMPLOYEE SHARE OPTION SCHEME 2025 (ORDINARY RESOLUTION 7) | | | |
| | Resolution 7 was to authorise the Directors to allot and issue shares under the AsiaMedic Employee Share Option Scheme 2025 (the "Scheme"). The text of the resolution was set out in the Notice of AGM.

Abstention from voting on resolution 7
The Chairman informed the meeting that all persons eligible to participate in the Scheme, including Directors, eligible employees of the Group or any associated Company, and their respective associates, would abstain from voting on Resolution | | | |

---

ASIAMEDIC LIMITED
Minutes of the AGM held on 29 April 2026
Page 5 of 5

7, unless they had been given specific instructions by the shareholders appointing them as proxy. Integral Lead Limited, being an associate of Ms Aona Liu, would also abstain from voting on this Resolution.

The resolution set out under item 8 of the Notice of the AGM was proposed by a shareholder.

The resolution was put to vote by poll. The result was as follows:

For	% of total votes	Against	% of total votes
37,146,000	99.20	300,000	0.80

The Chairman declared the resolution carried.

1. ANY OTHER BUSINESS

Before the close of the meeting, shareholders raised questions and the responses by Management were set out in Appendix 1 to the minutes.

The Company Secretary confirmed that there was no notice received for any other business.

1. CONCLUSION

The Chairman concluded the business for the meeting and declared the meeting closed at 3.25 p.m. with a vote of thanks to the attendees.

Confirmed by

Charles Wang Chong Guang
Chairman of the Meeting

These minutes have been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of these minutes, including the correctness of any of the statements or opinions made or reports contained in these minutes. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 6319 4954.

---

APPENDIX 1
TO THE MINUTES OF THE AGM HELD ON 29 APRIL 2026

Questions and suggestions from shareholders and the responses thereto have been collated and paraphrased as appropriate.

Question 1

The Company's financial performance has improved over the years. However, no dividend has been declared to date. Does the Company have any plans to distribute dividends to shareholders?

Response

The Company does not currently have a formal dividend policy. The Board would consider the declaration of dividends after taking into account various factors, including the Group's financial performance, capital expenditure requirements, cash position, and other relevant considerations. The Board remains mindful of shareholders' interests in this regard.

For the financial year ended 31 December 2025, taking into account the Company's accumulated losses as at 31 December 2025, the Board has decided not to declare a dividend for the financial year.

Should the Company's financial position improve in the next financial year, the Board may, at its discretion, revisit the matter at the appropriate time. In the meantime, the Company is exploring a capital reduction exercise to address the accumulated losses of the Company to facilitate the declaration and payment of dividends to shareholders, after taking into account, among others, the Group's financial performance and cash flow requirements.

Question 2

Does the Company have any plans for further expansion?

Response

The Company is continually exploring suitable growth and expansion opportunities as they arise.

Question 3

The share price is currently at 1 cent, which may reflect a weak brand image and potentially affect confidence in the Company's medical services. What steps are the Company taking to address this?

Response

The Company does not comment on or speculate about its share price movements. However, the Company strives to improve its operations and financial performance, and is continuously improving its facilities and strengthening its reputation in the market. In this regard, the Company has seen growing confidence from both doctors and patients in its services.